Ratings by Bloom Burton & Co.
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | David Martin | Aurinia Pharmaceuticals | AUPH | Upgrade | Buy (1) (Hold (3)) |
21.00 (N/A) |
16.17 (16.08) |
-0.56% | Details |
| 3/9/2026 | David Martin | Xenon Pharmaceuticals | XENE | Maintain | Buy (1) (N/A) |
74.00 (56.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 9 more... | |||||||||
